Lecanemab effectively targets amyloid plaques in people with Down syndrome, study finds People with Down syndrome are likely to develop Alzheimer’s disease at a young age. Autopsy studies show that by age…
Study uncovers how TREM2 R47H mutation affects Alzheimer’s plaques Researchers led by the University of California, Irvine, have discovered how the genetic mutation TREM2 R47H causes certain brain areas…
Dopamine treatment can reduce Alzheimer’s plaques and improve memory A new way to fight Alzheimer’s disease has been discovered by Takaomi Saido and his team at the RIKEN Center…
